Yahoo Finance

Orocidin develops novel cGMP manufacturing process in collaboration with Syngene

BEVERLY HILLS, California, Oct. 20, 2025 (GLOBE NEWSWIRE) -- Orocidin A/S (“Orocidin”), a subsidiary of Nordicus Partners Corporation (OTCQB: NORD) (“Nordicus” or the “Company”), a financial ...
Seeking Alpha

Orocidin, Syngene develop cGMP manufacturing process for peptide therapy

Orocidin A/S, a unit of Nordicus Partners (OTCQB:NORD), said on Monday it has developed a cGMP-compliant manufacturing process for its antimicrobial peptide QR-01 in collaboration with Syngene ...
Finanznachrichten

Nordicus Partners Corporation: Orocidin develops novel cGMP manufacturing process in ...

The partnership addressed complex peptide synthesis and purification challenges to achieve high yield and purity suitable for clinical use BEVERLY HILLS, California, Oct. 20, 2025 (GLOBE NEWSWIRE) -- ...

IQ, OQ, PQ in the Verification and Validation Process Training Course: Master V&V Planning ...

Market opportunities lie in enhancing risk-based V&V planning, focusing on DQ, IQ, OQ, and PQs to address cGMP deficiencies and regulatory expectations. By aligning with FDA, ICH, and ISO standards, ...
Mena FN

Orocidin Develops Novel Cgmp Manufacturing Process In Collaboration With Syngene

(MENAFN- GlobeNewsWire - Nasdaq) The partnership addressed complex peptide synthesis and purification challenges to achieve high yield and purity suitable for clinical use BEVERLY HILLS, California, ...